EARS Auris Medical Holding AG

0.79
-0.04  -5%
Previous Close 0.83
Open 0.87
Price To book 6.58
Market Cap 35020466
Shares 44,329,704
Volume 439,424
Short Ratio 1.46
Av. Daily Volume 367,240

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Open label safety trial data released April 24, 2017 and May 9, 2017.
Keyzilen (AM-101) - AMPACT open-label
Acute inner ear tinnitus
Phase 3 HEALOS completion of enrollment announced June 5, 2017. Data due 4Q 2017 (likely late November).
AM-111 HEALOS
Acute inner ear hearing loss
Phase 3 TACTT3 enrollment resumption announced January 26, 2017 with top-line data 1Q 2018.
Keyzilen (AM-101) - TACTT3
Acute inner ear tinnitus
Phase 3 ASSENT data due 2H 2018.
AM-111 ASSENT
Acute inner ear hearing loss
Phase 2 trial (REACH) enrollment pending funding.
AM-111 REACH
Surgery-induced hearing loss
Phase 3 trial did not meet primary endpoints
AM-101 (Keyzilen) - TACTT2
Acute inner ear tinnitus

Latest News

  1. Edited Transcript of EARS earnings conference call or presentation 14-Mar-16 12:00pm GMT
  2. Corporate News Blog - Auris Medical Executes Two Share Purchase Agreements with Lincoln Park Capital Fund
  3. Auris Medical Announces Share Purchase Agreements with Lincoln Park Capital Fund, LLC
  4. Auris Medical Announces Transfer to Nasdaq Capital Market
  5. Auris Medical Provides Board of Directors Update
  6. Auris Medical Completes Patient Recruitment for Phase 3 TACTT3 Trial of Keyzilen® in Acute and Post-Acute Tinnitus
  7. Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27
  8. Why Auris Medical Holding AG (EARS) Could Be A Buy
  9. Auris Medical to Host Scientific Symposium at the AAO-HNSF Annual Meeting
  10. Auris Medical Announces Receipt of Nasdaq Notice
  11. Edited Transcript of EARS earnings conference call or presentation 10-Aug-17 12:00pm GMT
  12. Auris reports 2Q loss
  13. Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results
  14. Investor Network: Auris Medical Holding AG to Host Earnings Call
  15. Auris Medical to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 10, 2017
  16. Edited Transcript of EARS earnings conference call or presentation 11-May-17 12:00pm GMT